Article Sidebar

PDF
Date Published: 21/06/2022
Abstract Views: 670
Views PDF: 626
DOI: https://doi.org/10.51298/vmj.v514i2.2632
Issue
Vol. 514 No. 2 (2022)
Section
Các bài báo
How to Cite
Huỳnh Kim Ngân, L. ., & Hữu Hên, P. . (2022). SURVEY OF THE SEVERE OF SECONDARY HYPERPARATHYROIDISM AND RELATED FACTORS IN PATIENTS WITH END-STAGE RENAL DISEASE PREPARING FOR KIDNEY TRANSPLANTATION. Vietnam Medical Journal, 514(2). https://doi.org/10.51298/vmj.v514i2.2632

SURVEY OF THE SEVERE OF SECONDARY HYPERPARATHYROIDISM AND RELATED FACTORS IN PATIENTS WITH END-STAGE RENAL DISEASE PREPARING FOR KIDNEY TRANSPLANTATION

Lâm Huỳnh Kim Ngân1,, Phan Hữu Hên1
1 Cho Ray Hospital

Main Article Content

Abstract

Target of researching: End-stage renal disease is one of the major global health burdens with many complications affecting the quality of life, namely hyperparathyroidism. This study was conducted to evaluate the severe of secondary hyperparathyroidism in patients with end-stage renal disease. Object and method of research: Retrospective study design on a group of patients preparing for kidney transplantation in 2020 at Cho Ray hospital. Study result: The prevalence of secondary hyperparathyroidism in patients with end-stage renal disease was 83.6% with a mean PTH concentration of 236.3 (1-999)pg/mL. Conclusion: Secondary hyperparathyroidism is a common complication in patients with end-stage renal disease who would be treated by kidney transplantation at Cho Ray hospital.

Article Details

Keywords

Secondary hyperparathyroidism, chronic kidney disease

References

1. Bộ y tế (2015), Hướng dẫn chẩn đoán và điều trị một số bệnh về thận - tiết niệu, Quyết định số 3931/QĐ-BYT ngày 21/9/2015 của Bộ trưởng Bộ Y tế.
2. Vũ Lệ Anh, Nguyễn Thành Tâm, Trần Thị Bích Hương, (2010), "Rối loạn chuyển hóa canxi, phospho và PTH ở bệnh nhân bệnh thận mạn giai đoạn trước chạy thận nhân tạo ", Tạp chí Y học Thành phố Hồ Chí Minh. 14, trang. 407-413.
3. Nguyễn Thanh Minh (2021), “Nghiên cứu rối loạn xương, khoáng và các yếu tố liên quan trên bệnh nhân bệnh thận mạn giai đoạn 5 lọc máu chu kỳ”, Luận án tiến sĩ y học, Đại học Y Huế
4. Andrew S. L., Kai-uwe E., Yusuke T., et al (2005), "Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)", Kidney International,. 67, pp. 2089–2100.
5. Ghosh B., Brojen T, Banerjee S., et al (2012), "The high prevalence of chronic kidney disease mineral bone disorders: A hospital-based crosssectional study", Indian Journal of Nephrology. 22. pp 285-291.
6. International society of nephrology (2017), "KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKDMBD)", Kidney International Supplements. 7, pp. 1-59.
7. Levin A, et al. (2007), "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease", Kidney Int. 71(1), pp. 31-38.
8. Miller P. D (2014), "Chronic kidney disease and osteoporosis: evaluation and management", Bonekey Rep. 3 (542), pp. 1-7.